Intangible Assets, Net (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Jun. 30, 2025 |
Nov. 05, 2024 |
|
| Intangible Assets, Net [Line Items] | ||||||
| Intangible assets, gross | $ 418,867 | $ 418,867 | $ 418,867 | |||
| Impairment expense | ||||||
| Amortization expenses | 21,370 | $ 32,056 | 64,112 | $ 32,056 | ||
| License [Member] | ||||||
| Intangible Assets, Net [Line Items] | ||||||
| Intangible assets, gross | $ 418,867 | $ 418,867 | ||||
| Hupan Pharmaceutical [Member] | ||||||
| Intangible Assets, Net [Line Items] | ||||||
| Equity interest percentage | 100.00% | |||||
| X | ||||||||||
- Definition Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, before accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of impairment loss for finite- and indefinite-lived intangible assets, goodwill, and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|